BACKGROUND Associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)has been adopted by liver surgeons in recent years.However,high morbidity and mortality rates have limited the promotion of ...BACKGROUND Associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)has been adopted by liver surgeons in recent years.However,high morbidity and mortality rates have limited the promotion of this technique.Some recent studies have suggested that ALPPS with a partial split can effectively induce the growth of future liver remnant(FLR)similar to a complete split with better postoperative safety profiles.However,some others have suggested that ALPPS can induce more rapid and adequate FLR growth,but with the same postoperative morbidity and mortality rates as in partial split of the liver parenchyma in ALPPS(p-ALPPS).AIM To perform a systematic review and meta-analysis on ALPPS and p-ALPPS.METHODS A systematic literature search of PubMed,Embase,the Cochrane Library,and ClinicalTrials.gov was performed for articles published until June 2019.Studies comparing the outcomes of p-ALPPS and ALPPS for a small FLR in consecutive patients were included.Our main endpoints were the morbidity,mortality,and FLR hypertrophy rates.We performed a subgroup analysis to evaluate patients with and without liver cirrhosis.We assessed pooled data using a random-effects model.RESULTS Four studies met the inclusion criteria.Four studies reported data on morbidity and mortality,and two studies reported the FLR hypertrophy rate and one study involved patients with cirrhosis.In the non-cirrhotic group,p-ALPPS-treated patients had significantly lower morbidity and mortality rates than ALPPStreated patients[odds ratio(OR)=0.2;95%confidence interval(CI):0.07–0.57;P=0.003 and OR=0.16;95%CI:0.03-0.9;P=0.04].No significant difference in the FLR hypertrophy rate was observed between the two groups(P>0.05).The total effects indicated no difference in the FLR hypertrophy rate or perioperative morbidity and mortality rates between the ALPPS and p-ALPPS groups.In contrast,ALPPS seemed to have a better outcome in the cirrhotic group.CONCLUSION The findings of our study suggest that p-ALPPS is safer than ALPPS in patients without cirrhosis and exhibits the same rate of FLR hypertrophy.展开更多
目的探讨终末期肾病(end-stage renal disease,ESRD)患者及家属对预立医疗照护计划(advance care planning,ACP)的态度、现状及影响因素。方法检索PubMed、Web of Science、中国知网、万方等数据库,筛选ESRD患者及家属对ACP的态度、现...目的探讨终末期肾病(end-stage renal disease,ESRD)患者及家属对预立医疗照护计划(advance care planning,ACP)的态度、现状及影响因素。方法检索PubMed、Web of Science、中国知网、万方等数据库,筛选ESRD患者及家属对ACP的态度、现状及影响因素相关研究,采用混合研究系统评价方法,对纳入文献进行质量评价和整合分析。结果共纳入18篇文献,归纳3个整合结果:对ACP的认识与态度;实施ACP的现状;实施ACP的影响因素。结论护理人员应运用新媒体加强ACP宣传力度,联合家属早期识别患者需求,建立多学科团队协作模式。通过引导更多ESRD患者及家属参与ACP讨论,有助于建立ACP的正确认识和积极态度。展开更多
文摘BACKGROUND Associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)has been adopted by liver surgeons in recent years.However,high morbidity and mortality rates have limited the promotion of this technique.Some recent studies have suggested that ALPPS with a partial split can effectively induce the growth of future liver remnant(FLR)similar to a complete split with better postoperative safety profiles.However,some others have suggested that ALPPS can induce more rapid and adequate FLR growth,but with the same postoperative morbidity and mortality rates as in partial split of the liver parenchyma in ALPPS(p-ALPPS).AIM To perform a systematic review and meta-analysis on ALPPS and p-ALPPS.METHODS A systematic literature search of PubMed,Embase,the Cochrane Library,and ClinicalTrials.gov was performed for articles published until June 2019.Studies comparing the outcomes of p-ALPPS and ALPPS for a small FLR in consecutive patients were included.Our main endpoints were the morbidity,mortality,and FLR hypertrophy rates.We performed a subgroup analysis to evaluate patients with and without liver cirrhosis.We assessed pooled data using a random-effects model.RESULTS Four studies met the inclusion criteria.Four studies reported data on morbidity and mortality,and two studies reported the FLR hypertrophy rate and one study involved patients with cirrhosis.In the non-cirrhotic group,p-ALPPS-treated patients had significantly lower morbidity and mortality rates than ALPPStreated patients[odds ratio(OR)=0.2;95%confidence interval(CI):0.07–0.57;P=0.003 and OR=0.16;95%CI:0.03-0.9;P=0.04].No significant difference in the FLR hypertrophy rate was observed between the two groups(P>0.05).The total effects indicated no difference in the FLR hypertrophy rate or perioperative morbidity and mortality rates between the ALPPS and p-ALPPS groups.In contrast,ALPPS seemed to have a better outcome in the cirrhotic group.CONCLUSION The findings of our study suggest that p-ALPPS is safer than ALPPS in patients without cirrhosis and exhibits the same rate of FLR hypertrophy.
文摘目的探讨终末期肾病(end-stage renal disease,ESRD)患者及家属对预立医疗照护计划(advance care planning,ACP)的态度、现状及影响因素。方法检索PubMed、Web of Science、中国知网、万方等数据库,筛选ESRD患者及家属对ACP的态度、现状及影响因素相关研究,采用混合研究系统评价方法,对纳入文献进行质量评价和整合分析。结果共纳入18篇文献,归纳3个整合结果:对ACP的认识与态度;实施ACP的现状;实施ACP的影响因素。结论护理人员应运用新媒体加强ACP宣传力度,联合家属早期识别患者需求,建立多学科团队协作模式。通过引导更多ESRD患者及家属参与ACP讨论,有助于建立ACP的正确认识和积极态度。
